Filter Results
:
(231)
Show Results For
-
All HBS Web
(1,361)
- Faculty Publications (231)
Show Results For
-
All HBS Web
(1,361)
- Faculty Publications (231)
←
Page 12 of
231
Results
- November 2001
- Case
Aventis CropScience and StarLink Corn
By: Ray A. Goldberg and James M Beagle
Aventis CropScience responds to the discovery of an unapproved corn variety in food supplies and draws lessons for the company, industry, and governments.
View Details
- August 2001
- Case
Scios, Inc.
Scios, filled with distinguished scientists and experienced managers, nevertheless fails to clear the FDA Phase III process for an important biotechnology drug. This case asks the students to analyze the social costs and benefits of the regulatory process.
View Details
- March 1999
- Case
Merck & Co., Inc.: Corporate Strategy, Organization and Culture (A)
By: Michael Beer and Perry Fagan
In the early 1990s, Merck faced a series of challenges because of significant changes in its competitive and regulatory environment (e.g., growth in power of pharmaceutical buyers like managed care organizations led to price pressures and President Clinton's review of...
View Details
Keywords:
Organizational Change and Adaptation;
Business or Company Management;
Organizational Culture;
Problems and Challenges;
Management Practices and Processes;
Competitive Strategy;
Management Teams;
Health Care and Treatment;
Governing Rules, Regulations, and Reforms;
Situation or Environment;
Alignment;
Pharmaceutical Industry;
United States
Beer, Michael, and Perry Fagan. "Merck & Co., Inc.: Corporate Strategy, Organization and Culture (A)." Harvard Business School Case 499-054, March 1999.
- October 1997 (Revised April 2002)
- Case
Planned Parenthood Federation of America (A)
By: V. Kasturi Rangan and Elaine V. Backman
Outlines the dynamic shifts in the external environment surrounding Planned Parenthood's operations in 1994. Health care reform was threatening some of its core customer base. The organization had to come up with a strategy and a process for adapting to the new...
View Details
Rangan, V. Kasturi, and Elaine V. Backman. "Planned Parenthood Federation of America (A)." Harvard Business School Case 598-001, October 1997. (Revised April 2002.)
- October 1995
- Case
Singapore TradeNet: Beyond TradeNet to the Intelligent Island
By: Lynda M. Applegate, John L. King and Soon-Siong Neo
Describes the actions taken by the government of Singapore to enable the country to survive and prosper after it achieved independence in the late 1960s. Recognizing that its small size, limited natural resources, but excellent location placed it in a vulnerable...
View Details
Keywords:
Transition;
Communication Technology;
Governing Rules, Regulations, and Reforms;
Policy;
Digital Platforms;
Information Technology;
Technology Adoption;
Information Technology Industry;
Singapore
Applegate, Lynda M., John L. King, and Soon-Siong Neo. "Singapore TradeNet: Beyond TradeNet to the Intelligent Island." Harvard Business School Case 196-105, October 1995.
- September 1995
- Case
Ares-Serono
By: Michael Y. Yoshino, Jean-Pierre Jeannet and Carin-Isabel Knoop
Ares Serono, a medium-size Swiss pharmaceutical company, is the global leader in the field of fertility drugs. The company has successfully transformed into one of the very few biotech firms in Europe. The case treats a set of major strategic and organizational...
View Details
Keywords:
Geographic Location;
Globalized Firms and Management;
Asset Management;
Balance and Stability;
Expansion;
Digital Platforms;
Leadership Development;
Health Care and Treatment;
Transformation;
Family Business;
Problems and Challenges;
Pharmaceutical Industry;
Biotechnology Industry;
Switzerland;
Europe
Yoshino, Michael Y., Jean-Pierre Jeannet, and Carin-Isabel Knoop. "Ares-Serono." Harvard Business School Case 396-035, September 1995.
- September 1991 (Revised February 1993)
- Case
Burroughs Wellcome and AZT (A)
Burroughs Wellcome Co., developer of AZT, the first drug approved by the U.S. Food and Drug Administration for the treatment of Acquired Immune Deficiency Syndrome (AIDS), finds itself under siege in September 1989 by AIDS activists and various segments of the U.S....
View Details
Keywords:
Governing Rules, Regulations, and Reforms;
Ethics;
Business and Government Relations;
Communication Strategy;
Health Care and Treatment;
Monopoly;
Intellectual Property;
Research and Development;
Price;
Pharmaceutical Industry;
London
Emmons, Willis M., III. "Burroughs Wellcome and AZT (A)." Harvard Business School Case 792-004, September 1991. (Revised February 1993.)
- Research Summary
Current Research
By: Leslie K. John
Professor John is a behavioral scientist who uses both laboratory and field experiments to investigate questions that are at the intersection of marketing, organizational behavior, and public policy.
Professor John’s work has been published in leading... View Details
- Teaching Interest
Overview
By: Leemore S. Dafny
U.S. Healthcare Strategy
The U.S. healthcare sector accounts for 17 percent of GDP, and encompasses a diverse set of industries with public, nonprofit, and for-profit buyers and sellers. There are significant concerns about high and rising spending, and...
View Details
- Forthcoming
- Article
Technological Adoption and Taxation: The Case of China's Golden Tax Reform
By: Haichao Fan, Yu Liu, Nancy Qian and Jaya Y. Wen
This paper investigates the effect of Phase 2 of the Golden Tax Project on VAT in China. The reform introduced computer-generated invoices and electronic transaction linking. Using a difference-in-differences strategy, we show that the reform increased VAT by reducing...
View Details
Keywords:
Taxation;
Governing Rules, Regulations, and Reforms;
Technological Innovation;
Economic Growth;
China
Fan, Haichao, Yu Liu, Nancy Qian, and Jaya Y. Wen. "Technological Adoption and Taxation: The Case of China's Golden Tax Reform." Tax Policy and the Economy (forthcoming). (To appear in Volume 38 (2024))
- Forthcoming
- Article
Tepid Uptake of Digital Health Technologies in Clinical Trials by Pharmaceutical and Medical Device Firms
By: Caroline Marra and Ariel D. Stern
Digital health technologies (DHTs) can enable more patient-centric therapeutic development by generating evidence that captures how patients feel and function, enabling decentralized trial designs that increase participant inclusivity and convenience, and collecting...
View Details
Keywords:
Health Care and Treatment;
Technological Innovation;
Product Development;
Health Testing and Trials;
Governing Rules, Regulations, and Reforms
Marra, Caroline, and Ariel D. Stern. "Tepid Uptake of Digital Health Technologies in Clinical Trials by Pharmaceutical and Medical Device Firms." Clinical Pharmacology & Therapeutics (forthcoming). (Pre-published online February 2, 2024.)
- ←
- 12